學士後中醫學系(含碩士班)

Artemisia argyi-enhanced Mesenchymal Stem Cell Exosomes Alleviates Inflammation in C28/I2 Chondrocytes by inhibiting NF-κB
Kao, S. W., Hsu, Y. T., Kuo, W. W., Huang, T. L., Lin, K. H., Kuo, C. H., Hsieh, D. J. Y., Ho, T. J., Lin, S. Z. & Huang, C. Y., 2026, 於: International Journal of Medical Sciences. 23, 3, p. 1092-1104 13 p.
研究成果: 期刊稿件 › 文章 › 同行評審

開啟存取
1 引文斯高帕斯（Scopus）
Comparative efficacy of immune checkpoint inhibitor-based regimens versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma stratified by etiology: a systematic review and meta-analysis
Peng, T. R., Huang, Y. H., Wu, T. W., Wu, C. C., Hsu, S. Y. & Hsu, C. S., 4月 2026, 於: International Journal of Clinical Oncology. 31, 4, p. 703-719 17 p.
研究成果: 期刊稿件 › 文章 › 同行評審
GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation
Chan, S. H., Li, P. Y., Li, P. H., Lin, Y. J., Wang, W. H., Huang, Y. N. & Chen, J. Y., 1月 2026, 於: Diabetes Research and Clinical Practice. 231, 113073.
研究成果: 期刊稿件 › 文章 › 同行評審

開啟存取
1 引文斯高帕斯（Scopus）

【第五屆慈濟論壇】全球防災與永續發展
許木柱 (參與者), 何日生 (參與者), Hsiao, H.-Y. (參與者), Jane, W.-L. (參與者), Tan, A. Y. K. (參與者), Lin, I.-H. (參與者) & Liu, I. Y. (參與者)
19 9月 2019 → 20 9月 2019
活動: 組織會議、研討會，…

指紋